1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4:

Imaging features in patients with infection, sepsis, and shock

Pt #Imaging Locations of PRES Vasogenic EdemaMRAImaging ModalityDWIF/U ImagingClinical at DischargeEdema GradeMAP
CTOPFMisc
Group1
    1xxxMRn/oResolved386
    2Spasm-impMRNegRes278
    3xxxxMRNegResolvingResolved587
    4xxxxxtPruningMRn/oResolved5104
    5xxxxCTRes398
    6xCTExpired2106
    7PruningMRNegResolvingResolved2101
    8xxxxCTRes5104
    9xxxxNormalMRNegRes293
    10xxxMRNeg*ResolvingResolved485
Group 2
    11xxxxt mbSpasm/prunMRNegNormal2138
    12xxxxMRNegRes3140
    13xxxxxbs mb cMRNegRes1133
    14xxxxxbsMRNegRes3135
    15xxxxCTResolved1126
    16xxxCTExpired2123
    17xxxtSpasmMRNegResolvingResolved2148
    18xxxxSpasmMRNegResolvingResolved3129
    19xxxSpasm-revMRNegRes1133
    20xxxxbsMRNegResolvingResolved2141
    21xxMRNegResolved1157
    22xxxxSpasmMRNegRes4130
    23xxxxMRNegRes1143
    24xxxxSpasm-revMRNeg*Res*3143
    25xxxxMRn/oRes2140
  • Note:—PRES indicates posterior reversible encephalopathy syndrome; C, cerebellum; T, temporal lobe/inferior temporal-occipital junction; O, occipital lobe; P, parietal region; F, frontal lobes; bs, brain stem including medulla and pons; mb, midbrain; t, thalamus; c, caudate nucleus; rev, spasm reverses; imp, spasm improves; spasm/prun, middle crebral artery spasm with posterior cerebral artery pruning; DWI, diffusion-weighted image characteristics; n/o, DWI not obtained with MR imaging study; Neg, no evidence of restricted diffusion to suggest cytotoxic edema; Neg*, no restricted diffusion in the majority of vasogennic edema with focal region of restricted diffusion and hemorrhage noted; Res, vasogenic edema completely resolved on follow-up imaging studies; Res*, vasogenic edema resolved with minor persistent abnormal signal in region of previously noted restricted diffusion, infarction, or focal hemorrhage; Resolving, resolving vasogenic edema on follow-up imaging studies or resolving clinical symptoms related to PRES; Resolved, clinical symptoms at PRES neurotoxicity resolved; MAP, mean arterial pressure.